Paclitaxel Treatment Options in Canada

A collection of 342 research studies where Paclitaxel is the interventional treatment. These studies are located in the Canada . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

Canada

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

NCT01166542

Completed

The purpose of this Phase 3 study is to evaluate overall survival and progression free survival following intravenous administration of REOLYSIN (Reovirus Serotype 3 Dearing) in combination with paclitaxel and carboplatin versus chemotherapy treatment alone, in patients with metastatic or recurrent Squamous Cell Carcinoma of the Head and Neck.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/03/2014

Locations: University of Alabama at Birmingham, Birmingham, Alabama +76 locations

University of Alabama at Birmingham, Birmingham, Alabama

Arizona Oncology Associates, Tucson, Arizona

Providence Health and Services, Burbank, California

Wilshire Oncology Medical Group, Corona, California

BMS Physician Practice, A Medical Corporation DBA Medical Oncology Care Associates, Orange, California

Rocky Mountain Cancer Centers, Denver, Colorado

Pasco Hernando Oncology Associates, PA, New Port Richey, Florida

Emory University - Winship Cancer Institute, Altanta, Georgia

Alexian Brothers Hospital Network, Elk Grove Village, Illinois

Mary Bird Perkinds Cancer Center - Baton Rouge, Baton Rouge, Louisiana

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada

Montefiore Medical Center, Bronx, New York

Case Comprehensive Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio

Mercy Cancer Center, Toledo, Ohio

Medical University of South Carolina, Charleston, South Carolina

Texas Oncology- Sammons Cancer Center, Dallas, Texas

Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas

Texas Oncology - Tyler, Tyler, Texas

Columbia Basin Hematology and Oncology, Kennewick, Washington

ZNA Middelheim, Antwerpen, Not set

University Hospital Antwerp, Edegem, Not set

Universitair Ziekenhuis Brussel, Jette, Not set

Tom Baker Cancer Centre, Calgary, Alberta

Juravinski Cancer Center, Hamilton, Ontario

London Health Sciences Centre, London, Ontario

Hopital Notre-Dame, Montreal, Quebec

Hopital Saint-André / Service d'Oncologie-Radiothérapie, Bordeaux, Not set

Centre Antoine Lacassagne / Oncologie Médicale, Nice, Not set

Institut Curie / Département d'Oncologie Médicale, Paris, Not set

UKE Hamburg, Hamburg, Not set

Attikon University Hospital, Athens, Not set

Fovarosi Onkormanyzat Uzsoki Utcai Kórház, Budapest, Not set

Orszagos Onkologiai Intezet, Budapest, Not set

Pecsi Tudomanyegyetem, Pecs, Not set

Szegedi Tudományegyetem, Szegedi, Not set

Markusovszky Korhaz, Szombathely, Not set

Ufficio Sperimentazioni Cliniche c/o S.C. Oncologia Medica, Cuneo, Not set

Fondazione IRCCS Istituto Nazionale del Tumori, Milan, Not set

Ospedale San Paolo - Oncologia Medica, Milan, Not set

University Hospital in Modena, Modena, Not set

Centrum Onkologii - Instytyt im.M.Skłodowskiej-Curie, Krakow, Not set

Szpital MSWiA - Centrum Onkologi, Olsztyn, Not set

Wielkopolskie Centrum Onkologii, Poznań, Not set

Wojewódzki Szpital Specjalistyczny im. M.Kopernika, Łódź, Not set

State Health Care Institution "Arkhangelsk Regional Clinical Oncology Dispensary", Arkhangelsk, Not set

Regional State Health Care Institution "Belgorod Oncology Dispensary", Belgorod, Not set

State Health Care Institution "Chelyabinsk Regional Oncology Dispensary", Chelyabinsk, Not set

State Health Care Institution "Republican Clinical Oncology Dispensary of Ministry of Health of the Republic of Tatarstan", Kazan, Not set

State Budgetary Health Care Institution "Clinical Oncology Dispensary #1" of Krasnodar Region Health Care Department, Krasnodar, Not set

Regional Budgetary Health Care Institution "Kursk Regional Oncology Dispensary" of Health Care Committee of Kursk region, Kursk, Not set

Federal State Budgetary Institution "Medical Research Radiology Center" of Ministry of Public Health and Social Development of Russian Federation, Obninsk, Obninsk, Not set

Federal State Budgetary Institution "Russian Research Centre of Radiology and Surgery technologies" of Ministry of Public Health and Social Development of the Russian Federation, Saint Petersburg, Not set

Federal State Budgetary Institution "N. N. Petrov Oncology Research Institute" of Ministry of Public Health and Social Development of the Russian Federation, Saint-Petersburg, Not set

St.Petersburg State Health Care Institution City Clinical Oncology Dispensary", Saint-Petersburg, Not set

State Health Care Institution "Oncology Dispensary №2" of Krasnodar Region Health Care Department, Sochi, Not set

State Health Care Institution "Tula Regional Oncology Dispensary", Tula, Not set

State Budgetary Healthcare Institution "Republic Clinical Oncology Dispensary Ministry of Health of Bashkortostan", Ufa, Not set

State Budgetary Health Care Institution of the Yaroslavl region "Regional Clinical Oncological Hospital", Yaroslavl, Not set

Institute of Oncology Ljubljana, Ljubljana, Not set

Hospital Vall D'Hebron, Barcelona, Not set

Instituto Catlan de Oncologia (ICO) - Hospital Duran i Reynals, Barcelona, Not set

Hospital Clinic i Provincial de Barcelona, Barcelona, Not set

Hospital Santa Creu I Sant Pau, Barcelona, Not set

Instituto Catlan de Oncologia (ICO) - Hospital Germans Trias I Pujol, Barcelona, Not set

Hospital de Basurto, Bilbao, Not set

Hospital de Navarra, Pamplona, Not set

Beatson West of Scotland Cancer Center, Glasgow, Not set

Royal Surrey County Hospital, Guildford, Not set

St. James's University Hospital, Leeds, Not set

Guy's and St. Thomas Hospital, London, Not set

The Royal Marsden Cancer Center, Fulham Road branch, London, Not set

The Royal Marsden Cancer Center, Sutton Branch, Sutton, Not set

Musgrove Park Hospital, Taunton, Not set

The Velindre Hospital, Whitchurch, Not set

Clatterbridge Centre for Oncology NHS Foundation Trust, Wirral, Not set

Conditions: Carcinoma, Squamous Cell of the Head and Neck

Learn More ›

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

NCT00300885

Terminated

A randomized controlled trial comparing safety and efficacy of carboplatin and paclitaxel plus or minus sorafenib in chemonaive patients with stage III-IV non-small cell lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/28/2014

Locations: Not set, Birmingham, Alabama +201 locations

Not set, Birmingham, Alabama

Not set, Mobile, Alabama

Not set, Tucson, Arizona

Not set, Little Rock, Arkansas

Not set, Springdale, Arkansas

Not set, Anaheim, California

Not set, Beverly Hills, California

Not set, Burbank, California

Not set, Corona, California

Not set, Encinitas, California

Not set, Highland, California

Not set, Los Angeles, California

Not set, Orange, California

Not set, Sacramento, California

Not set, Denver, Colorado

Not set, Lakeland, Florida

Not set, Merritt Island, Florida

Not set, Orlando, Florida

Not set, Atlanta, Georgia

Not set, Marietta, Georgia

Not set, Savannah, Georgia

Not set, Chicago, Illinois

Not set, Skokie, Illinois

Not set, Fort Wayne, Indiana

Not set, Indianapolis, Indiana

Not set, Kokomo, Indiana

Not set, Sioux City, Iowa

Not set, Hutchinson, Kansas

Not set, Wichita, Kansas

Not set, Louisville, Kentucky

Not set, Baton Rouge, Louisiana

Not set, Metairie, Louisiana

Not set, Boston, Massachusetts

Not set, Pittsfield, Massachusetts

Not set, Ann Arbor, Michigan

Not set, Detroit, Michigan

Not set, Hattiesburg, Mississippi

Not set, Jefferson City, Missouri

Not set, Kansas City, Missouri

Not set, St. Louis, Missouri

Not set, Lincoln, Nebraska

Not set, Las Vegas, Nevada

Not set, Hackensack, New Jersey

Not set, Morristown, New Jersey

Not set, New York, New York

Not set, Rochester, New York

Not set, Staten Island, New York

Not set, Bismarck, North Dakota

Not set, Fargo, North Dakota

Not set, Columbus, Ohio

Not set, Dayton, Ohio

Not set, Dover, Ohio

Not set, Oklahoma City, Oklahoma

Not set, Tulsa, Oklahoma

Not set, Portland, Oregon

Not set, Allentown, Pennsylvania

Not set, Bethlehem, Pennsylvania

Not set, Philadelphia, Pennsylvania

Not set, Pottsville, Pennsylvania

Not set, Sayre, Pennsylvania

Not set, Charleston, South Carolina

Not set, Greenville, South Carolina

Not set, Knoxville, Tennessee

Not set, Nashville, Tennessee

Not set, Trophy Club, Texas

Not set, Salt Lake City, Utah

Not set, Abingdon, Virginia

Not set, Fairfax, Virginia

Not set, Richlands, Virginia

Not set, Richmond, Virginia

Not set, Morgantown, West Virginia

Not set, Milwaukee, Wisconsin

Not set, El Palomar - Morón, Buenos Aires

Not set, La Plata, Buenos Aires

Not set, Mar del Plata, Buenos Aires

Not set, Buenos Aires, Ciudad Auton. de Buenos Aires

Not set, Rosario, Santa Fe

Not set, Capital Federal-Buenos Aires, Not set

Not set, Santa Fé, Not set

Not set, Port Macquarie, New South Wales

Not set, Wollongong, New South Wales

Not set, Brisbane, Queensland

Not set, Adelaide, South Australia

Not set, Frankston, Victoria

Not set, Melbourne, Victoria

Not set, Perth, Western Australia

Not set, Bruxelles - Brussel, Not set

Not set, Charleroi, Not set

Not set, La Louviere, Not set

Not set, Liege, Not set

Not set, Salvador, Bahia

Not set, Fortaleza, Ceará

Not set, Brasília, Distrito Federal

Not set, Goiânia, Goiás

Not set, Nova Lima, Minas Gerais

Not set, Curitiba, Parana

Not set, Porto Alegre, Rio Grande do Sul

Not set, Joinville, Santa Catarina

Not set, Barretos, Sao Paulo

Not set, Jaú, Sao Paulo

Not set, Ribeirao Preto, Sao Paulo

Not set, Santo Andre, Sao Paulo

Not set, Sorocaba, Sao Paulo

Not set, São Paulo, Sao Paulo

Not set, Belo Horizonte, Not set

Not set, North Vancouver, British Columbia

Not set, Barrie, Ontario

Not set, Brampton, Ontario

Not set, Montreal, Quebec

Not set, Regina, Saskatchewan

Not set, Santiago, Not set

Not set, Bobigny Cedex, Not set

Not set, Caen, Not set

Not set, Clamart, Not set

Not set, Metz, Not set

Not set, Nancy, Not set

Not set, Nice Cedex 2, Not set

Not set, Strasbourg, Not set

Not set, Heidelberg, Baden-Württemberg

Not set, Mannheim, Baden-Württemberg

Not set, Gauting, Bayern

Not set, München, Bayern

Not set, Hofheim, Hessen

Not set, Göttingen, Niedersachsen

Not set, Hannover, Niedersachsen

Not set, Oldenburg, Niedersachsen

Not set, Essen, Nordrhein-Westfalen

Not set, Hemer, Nordrhein-Westfalen

Not set, Leverkusen, Nordrhein-Westfalen

Not set, Mainz, Rheinland-Pfalz

Not set, Großhansdorf, Schleswig-Holstein

Not set, Berlin, Not set

Not set, Hamburg, Not set

Not set, Hong Kong, Not set

Not set, Budapest, Not set

Not set, Deszk, Not set

Not set, Gyula, Not set

Not set, Matrahaza, Not set

Not set, Torokbalint, Not set

Not set, Orbassano, Torino

Not set, Bergamo, Not set

Not set, Genova, Not set

Not set, Milano, Not set

Not set, Parma, Not set

Not set, Pavia, Not set

Not set, Perugia, Not set

Not set, Roma, Not set

Not set, Torino, Not set

Not set, Seoul, Not set

Not set, Eindhoven, Noord-Brabant

Not set, Zwolle, Not set

Not set, Gdansk, Not set

Not set, Krakow, Not set

Not set, Olsztyn, Not set

Not set, Otwock, Not set

Not set, Warszawa, Not set

Not set, Wroclaw, Not set

Not set, San Juan, Not set

Not set, Moscow, Not set

Not set, St. Petersburg, Not set

Not set, Elche, Alicante

Not set, Zaragoza, Aragón

Not set, Majadahonda, Madrid

Not set, Alicante, Not set

Not set, Barcelona, Not set

Not set, Madrid, Not set

Not set, Pontevedra, Not set

Not set, Zamora, Not set

Not set, Gävle, Not set

Not set, Stockholm, Not set

Not set, Uppsala, Not set

Not set, Taichung, Not set

Not set, Taipei, Not set

Not set, Taoyuan, Not set

Not set, Plymouth, Devon

Not set, Bornemouth, Dorset

Not set, Leicester, Leicestershire

Not set, London, Not set

Not set, Manchester, Not set

Conditions: Carcinoma, Non-Small Cell Lung

Learn More ›

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

NCT00111007

Completed

The objectives of this study are to compare the anti-tumor activity as measured by Progression Free Survival (PFS) and tolerability of Sorafenib in combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in combination with placebo in subjects with unresectable Stage III or Stage IV melanoma who progressed after receiving only one prior therapy containing Dacarbazine (DTIC) or Temozolomide (TMZ).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/23/2014

Locations: Not set, Birmingham, Alabama +65 locations

Not set, Birmingham, Alabama

Not set, Tucson, Arizona

Not set, Los Angeles, California

Not set, Aurora, Colorado

Not set, Tampa, Florida

Not set, Chicago, Illinois

Not set, Park Ridge, Illinois

Not set, Louisville, Kentucky

Not set, St. Louis, Missouri

Not set, Omaha, Nebraska

Not set, Montclair, New Jersey

Not set, Buffalo, New York

Not set, New York, New York

Not set, Columbus, Ohio

Not set, Pittsburgh, Pennsylvania

Not set, Nashville, Tennessee

Not set, Houston, Texas

Not set, Charlottesville, Virginia

Not set, Seattle, Washington

Not set, Camperdown, New South Wales

Not set, Warartah, New South Wales

Not set, Westmead, New South Wales

Not set, Brisbane, Queensland

Not set, East Melbourne, Victoria

Not set, Heidelberg, Victoria

Not set, Malvern, Victoria

Not set, Melbourne, Victoria

Not set, Nedlands, Western Australia

Not set, Calgary, Alberta

Not set, Edmonton, Alberta

Not set, London, Ontario

Not set, Toronto, Ontario

Not set, Montreal, Quebec

Not set, Bordeaux, Not set

Not set, Boulogne-billancourt, Not set

Not set, Brest, Not set

Not set, Lyon Cedex, Not set

Not set, Montpellier Cedex, Not set

Not set, Paris, Not set

Not set, Villejuif, Not set

Not set, Heidelberg, Baden-Württemberg

Not set, Mannheim, Baden-Württemberg

Not set, Tübingen, Baden-Württemberg

Not set, München, Bayern

Not set, Frankfurt, Hessen

Not set, Essen, Nordrhein-Westfalen

Not set, Trier, Rheinland-Pfalz

Not set, Homburg, Saarland

Not set, Kiel, Schleswig-Holstein

Not set, Berlin, Not set

Not set, Amsterdam, Not set

Not set, Rotterdam, Not set

Not set, Utrecht, Not set

Not set, Southampton, Hampshire

Not set, Leicester, Leicestershire

Not set, Bebington, Merseyside

Not set, Nottingham, Nottinghamshire

Not set, Sutton, Surrey

Not set, Leeds, West Yorkshire

Not set, London, Not set

Not set, Manchester, Not set

Not set, Swansea, Not set

Conditions: Melanoma

Learn More ›

A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer

NCT00475670

Completed

This 2 arm study will assess the efficacy and safety of intravenous Herceptin with or without a taxane for the first line treatment of metastatic breast cancer in women who have relapsed at least 12 months after a minimum of 10 months of (neo)adjuvant treatment with Herceptin for HER2-positive early breast cancer.Patients will receive either Herceptin monotherapy (loading dose of 4mg/kg iv, followed by weekly doses of 2mg/kg iv, or 8mg/kg loading dose followed by 3-weekly doses of 6mg/kg)or Herc... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

09/09/2014

Locations: Not set, Geelong, Victoria +56 locations

Not set, Geelong, Victoria

Not set, Klagenfurt, Not set

Not set, Salzburg, Not set

Not set, Vöcklabruck, Not set

Not set, Wien, Not set

Not set, Brussel, Not set

Not set, Namur, Not set

Not set, Porto Alegre, RS

Not set, Winnipeg, Manitoba

Not set, Brampton, Ontario

Not set, Oshawa, Ontario

Not set, Greenfield Park, Quebec

Not set, Beijing, Not set

Not set, Guangzhou, Not set

Not set, Shanghai, Not set

Not set, Wuhan, Not set

Not set, Berlin, Not set

Not set, Düsseldorf, Not set

Not set, Hamburg, Not set

Not set, Krefeld, Not set

Not set, Köln, Not set

Not set, Lemgo, Not set

Not set, München, Not set

Not set, Tübingen, Not set

Not set, Budapest, Not set

Not set, Kecskemet, Not set

Not set, Szeged, Not set

Not set, Chieti, Not set

Not set, Genova, Not set

Not set, Roma, Not set

Not set, San Giovanni Rotondo, Not set

Not set, Sassari, Not set

Not set, Merida, Not set

Not set, Panama City, Not set

Not set, Gdansk, Not set

Not set, Gliwice, Not set

Not set, Lodz, Not set

Not set, Kazan, Not set

Not set, Moscow, Not set

Not set, Saint-Petersburg, Not set

Not set, La Coruna, La Coruña

Not set, Barcelona, Not set

Not set, Jaen, Not set

Not set, Madrid, Not set

Not set, Valencia, Not set

Not set, Zaragoza, Not set

Not set, Changhua, Not set

Not set, Taipei, Not set

Not set, Taoyuan, Not set

Conditions: Breast Cancer

Learn More ›

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

NCT00408655

Completed

This phase I trial is studying the side effects and best dose of temsirolimus, carboplatin, and paclitaxel in treating patients with advanced solid tumors. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving temsirolimus together with chemotherapy may kill... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/18/2014

Locations: National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario

Conditions: Ovarian Sarcoma, Ovarian Stromal Cancer, Recurrent Endometrial Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Stage III Endometrial Carcinoma, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Endometrial Carcinoma, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific

Learn More ›

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

NCT00522834

Terminated

"Elesclomol (STA-4783), N-malonyl-bis (N'-methyl-N'-thiobenzoylhydrazide) is a new chemical entity with a novel structure. STA-4783 induces an oxidative stress response in cells. This response is characterized by increased production of gene families that protect against different cellular stresses, including excessive heat, the presence of reactive oxygen species such as oxygen radicals, or the presence of heavy metals. Subjects will participate in up to 2 weeks of screening during which time... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/31/2014

Locations: Arizona Cancer Center, Tucson, Arizona +100 locations

Arizona Cancer Center, Tucson, Arizona

Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas

University of California San Diego Moores UCSD Cancer Center, La Jolla, California

University of California, San Diego, La Jolla, California

The Angeles Clinic & Research Institute, Los Angeles, California

Jonsson Comprehensive Cancer Center Univ. of California Los Angeles, Los Angeles, California

Pacific Medical Center Research Institute, San Francisco, California

Redwood Regional Medical Group, Santa Rosa, California

Anschutz Cancer Pavillion University of Colorado, Aurora, Colorado

Hematology Oncology, P.C., Stamford, Connecticut

Bay Pines VA Healthcare System, Bay Pines, Florida

Univ. of Miami Hospital and Clinics, Miami, Florida

MD Anderson Cancer Center, Orlando, Florida

Piedmont Hospital, Atlanta, Georgia

Emory University Winship Cancer Institute, Atlanta, Georgia

Rush University Hospital, Chicago, Illinois

Evanston Northwestern Healthcare, Evanston, Illinois

Joliet Oncology/Hematology Associates, LTD, Joliet, Illinois

Oncology Specialists, S.C., Niles, Illinois

Oncology Specialists, SC, Park Ridge, Illinois

Goshen Center for Cancer Care, Goshen, Indiana

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Dana Farber Cancer Institute, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

Hubert H. Humphrey Cancer Center, Robbinsdale, Minnesota

Ellis Fischels Cancer Center, Columbia, Missouri

Southeast Nebraska Hematology/Oncology, Lincoln, Nebraska

Nebraska Methodist Cancer Center, Omaha, Nebraska

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Atlantic Health Research - Mountainside Hospital, Montclair, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Monter Cancer Center North Shore Hospital, Lake Success, New York

Weill Medical College of Cornell University - Division of Hematology and Medical Oncology, New York, New York

NYU Clinical Cancer Center, New York, New York

Stony Brook University Medical Center- Cancer Center, Stony Brook, New York

UNC School of Medicine - Division of Hematology/Oncology, Chapel Hill, North Carolina

Carolina Hematology & Oncology Associates, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

Leo W. Jenkins Cancer Center, Greenville, North Carolina

Brody School of Medicine at East Carolina State University, Greenville, North Carolina

Derrick L. Davis Regional Cancer Center, Winston-Salem, North Carolina

The Christ Hospital, Cincinnati, Ohio

The Ohio State University., Columbus, Ohio

Mark H. Zangmeister Cancer Center, Columbus, Ohio

Providence Cancer Center Clinical Trials, Portland, Oregon

St. Luke's Cancer Center, Bethlehem, Pennsylvania

Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Cancer Pavilion, Pittsburgh, Pennsylvania

Cancer Center of the Carolinas, Greenville, South Carolina

Vanderbilt Medical Center, Nashville, Tennessee

Texas Oncology, PA, Dallas, Texas

San Antonio Cancer Institute, San Antonio, Texas

Virginia Oncology Associates, Chesapeake, Virginia

Virginia Oncology Associates, Newport News, Virginia

Virginia Oncology Associates, Norfolk, Virginia

Virginia Cancer Institute, Richmond, Virginia

Seattle Cancer Care Alliance, Seattle, Washington

Marshfield Clinic, Marshfield, Wisconsin

Lismore Base Hospital, Cancer Care & Haematology Unit, Lismore, New South Wales

Newcastle Melanoma Unit - Calvary Mater Newcastle, Waratah, New South Wales

Southern Medical Day Care Centre, Wollongong, New South Wales

Redcliffe Hospital, Redcliffe, Queensland

Princess Alexandra Hospital, Wooloongabba, Queensland

Royal Hobart Hospital, Hobart, Tasmania

Fremantle Hospital, Fremantle, Western Australia

Royal Adelaide Cancer Centre Medical Oncology, Adelaide, Not set

Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, Not set

The Tweed Hospital, Tweed Heads, Not set

Department of Medical Oncology, Westmead Hospital, Westmead, Not set

Tom Baker Cancer Centre, Calgary, Alberta

QE II Health Sciences Center, Halifax, Nova Scotia

Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario

Cross Cancer Institute, Edmonton, Not set

Princess Margaret Hospital, Toranto, Not set

Vivantes Klinikum Im Friedrichshain, Berlin, Not set

Vivantes Klinikum Neukölln, Berlin, Not set

Elbe-Klinikum Buxtehude, Buxtehude, Not set

University Frankfurt, Frankfurt/Main, Not set

University of Kiel, Kiel, Not set

Universität zu Köln, Köln, Not set

Universitätsklinikum Leipzig, Leipzig, Not set

Universitätsklinikum Mannheim, Mannheim, Not set

Universitätsklinikum Münster, Münster, Not set

Universitätsklinikum Würzburg, Würzburg, Not set

VA Medical Center, San Juan, Not set

County Hospital Brasov - Oncology Department, Brasov, Not set

Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj Napoca, Not set

Clinical County Hospital " Alexandru Simionescu" Hunedoara, Hunedoara, Not set

Center of Medical Oncology, Iasi, Not set

Clinical County Hospital Sibiu, Sibiu, Not set

Oncology- Chemotherapy Clinic - Emergency Municipal Clinical Hospital, Timisoara, Not set

Hospital Universitario Central de Asturias, Oviedo, Asturias

Hospital Universitario de la Princessa Servicio de Oncología Médica, Madrid, Not set

Clinica Universitaria de Navarra, Pamplona, Not set

Hospital Virgen de la Salud - Servicio de Oncología Médica Ciclos, Toledo, Not set

Oncology Centre Addenbrookes's Hospital, Cambridge, Not set

Northern Centre for Cancer Treatment Newcastle General Hospital, Newcastle upon Tyne, Not set

Dorset Cancer Centre Poole Hospital NHS Foundation Trust, Poole, Not set

Conditions: Melanoma

Learn More ›

Treatment With Pazopanib for Neoadjuvant Breast Cancer

NCT00849472

Completed

The purpose of this study is to determine whether the treatment of a doxorubicin in combination with cyclophosphamide followed by a combination of pazopanib in combination with paclitaxel prior to surgery results in a pathological complete response in females with breast cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

01/30/2014

Locations: GSK Investigational Site, Decatur, Alabama +142 locations

GSK Investigational Site, Decatur, Alabama

GSK Investigational Site, Huntsville, Alabama

GSK Investigational Site, Antioch, California

GSK Investigational Site, Fremont, California

GSK Investigational Site, Hayward, California

GSK Investigational Site, Oakland, California

GSK Investigational Site, Redwood City, California

GSK Investigational Site, Richmond, California

GSK Investigational Site, Roseville, California

GSK Investigational Site, Sacramento, California

GSK Investigational Site, San Francisco, California

GSK Investigational Site, San Jose, California

GSK Investigational Site, San Rafael, California

GSK Investigational Site, Santa Clara, California

GSK Investigational Site, Santa Rosa, California

GSK Investigational Site, South San Francisco, California

GSK Investigational Site, Stockton, California

GSK Investigational Site, Vacaville, California

GSK Investigational Site, Vallejo, California

GSK Investigational Site, Walnut Creek, California

GSK Investigational Site, Colorado Springs, Colorado

GSK Investigational Site, Denver, Colorado

GSK Investigational Site, Englewood, Colorado

GSK Investigational Site, Greeley, Colorado

GSK Investigational Site, Lafayette, Colorado

GSK Investigational Site, Wheat Ridge, Colorado

GSK Investigational Site, Fernandina Beach, Florida

GSK Investigational Site, Gainesville, Florida

GSK Investigational Site, Jacksonville, Florida

GSK Investigational Site, Orange Park, Florida

GSK Investigational Site, Savannah, Georgia

GSK Investigational Site, Honolulu, Hawaii

GSK Investigational Site, Iowa City, Iowa

GSK Investigational Site, Jeffersonville, Kentucky

GSK Investigational Site, Louisville, Kentucky

GSK Investigational Site, Baltimore, Maryland

GSK Investigational Site, Ann Arbor, Michigan

GSK Investigational Site, Battle Creek, Michigan

GSK Investigational Site, Brighton, Michigan

GSK Investigational Site, Byron Center, Michigan

GSK Investigational Site, Dearborn, Michigan

GSK Investigational Site, Detroit, Michigan

GSK Investigational Site, Flint, Michigan

GSK Investigational Site, Grand Rapids, Michigan

GSK Investigational Site, Grosse Point Woods, Michigan

GSK Investigational Site, Lansing, Michigan

GSK Investigational Site, Livonia, Michigan

GSK Investigational Site, Mt. Clemens, Michigan

GSK Investigational Site, Muskegon, Michigan

GSK Investigational Site, Port Huron, Michigan

GSK Investigational Site, Saginaw, Michigan

GSK Investigational Site, Traverse City, Michigan

GSK Investigational Site, Warren, Michigan

GSK Investigational Site, Brunsville, Minnesota

GSK Investigational Site, Edina, Minnesota

GSK Investigational Site, Fridley, Minnesota

GSK Investigational Site, Maplewood, Minnesota

GSK Investigational Site, Minneapolis, Minnesota

GSK Investigational Site, Saint Paul, Minnesota

GSK Investigational Site, St. Louis Park, Minnesota

GSK Investigational Site, St. Paul, Minnesota

GSK Investigational Site, Woodbury, Minnesota

GSK Investigational Site, New Brunswick, New Jersey

GSK Investigational Site, Stony Brook, New York

GSK Investigational Site, Charlotte, North Carolina

GSK Investigational Site, Clinton, North Carolina

GSK Investigational Site, Goldsboro, North Carolina

GSK Investigational Site, Greenville, North Carolina

GSK Investigational Site, Wilson, North Carolina

GSK Investigational Site, Winston-Salem, North Carolina

GSK Investigational Site, Canton, Ohio

GSK Investigational Site, Chargrin, Ohio

GSK Investigational Site, Clevand, Ohio

GSK Investigational Site, Dayton, Ohio

GSK Investigational Site, Kettering, Ohio

GSK Investigational Site, Lebanon, Ohio

GSK Investigational Site, Mentor, Ohio

GSK Investigational Site, Middletown, Ohio

GSK Investigational Site, Westlake, Ohio

GSK Investigational Site, Wilminton, Ohio

GSK Investigational Site, Xenia, Ohio

GSK Investigational Site, Portland, Oregon

GSK Investigational Site, Ephrata, Pennsylvania

GSK Investigational Site, Greensburg, Pennsylvania

GSK Investigational Site, Philadelphia, Pennsylvania

GSK Investigational Site, Pittsburgh, Pennsylvania

GSK Investigational Site, West Reading, Pennsylvania

GSK Investigational Site, Lubbock, Texas

GSK Investigational Site, Richmond, Virginia

GSK Investigational Site, Seattle, Washington

GSK Investigational Site, Vancouver, Washington

GSK Investigational Site, Vancover, Washington

GSK Investigational Site, Chippewa Falls, Wisconsin

GSK Investigational Site, Eau Claire, Wisconsin

GSK Investigational Site, Marshfield, Wisconsin

GSK Investigational Site, Minocqua, Wisconsin

GSK Investigational Site, Rhinelander, Wisconsin

GSK Investigational Site, Rice Lake, Wisconsin

GSK Investigational Site, Stevens Point, Wisconsin

GSK Investigational Site, Weston, Wisconsin

GSK Investigational Site, Wisconsin Rapids, Wisconsin

GSK Investigational Site, Ottawa, Ontario

GSK Investigational Site, Montreal, Quebec

GSK Investigational Site, Quebec, Not set

Conditions: Neoplasms, Breast

Learn More ›

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

NCT00596830

Terminated

Determine whether the addition of CP- 751,871 in combination with paclitaxel plus carboplatin prolongs survival in patients with locally advanced (Stage IIIB with pleural effusion) or metastatic (Stage IV or recurrent) NSCLC of non adenocarcinoma histology.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/11/2013

Locations: Pfizer Investigational Site, Florence, Alabama +279 locations

Pfizer Investigational Site, Florence, Alabama

Pfizer Investigational Site, Huntsville, Alabama

Pfizer Investigational Site, Muscle Shoals, Alabama

Pfizer Investigational Site, Phoenix, Arizona

Pfizer Investigational Site, Scottsdale, Arizona

Pfizer Investigational Site, Hot Springs, Arkansas

Pfizer Investigational Site, Aurora, Colorado

Pfizer Investigational Site, Boulder, Colorado

Pfizer Investigational Site, Colorado Springs, Colorado

Pfizer Investigational Site, Denver, Colorado

Pfizer Investigational Site, Lakewood, Colorado

Pfizer Investigational Site, Littleton, Colorado

Pfizer Investigational Site, Lone Tree, Colorado

Pfizer Investigational Site, Longmont, Colorado

Pfizer Investigational Site, Parker, Colorado

Pfizer Investigational Site, Thornton, Colorado

Pfizer Investigational Site, Norwalk, Connecticut

Pfizer Investigational Site, Norwich, Connecticut

Pfizer Investigational Site, Hudson, Florida

Pfizer Investigational Site, Jacksonville, Florida

Pfizer Investigational Site, Lake City, Florida

Pfizer Investigational Site, Miramar Beach, Florida

Pfizer Investigational Site, New Port Richey, Florida

Pfizer Investigational Site, Orlando, Florida

Pfizer Investigational Site, Pensacola, Florida

Pfizer Investigational Site, Port St. Lucie, Florida

Pfizer Investigational Site, Spring Hill, Florida

Pfizer Investigational Site, Alpharetta, Georgia

Pfizer Investigational Site, Atlanta, Georgia

Pfizer Investigational Site, Conyers, Georgia

Pfizer Investigational Site, Cumming, Georgia

Pfizer Investigational Site, Decatur, Georgia

Pfizer Investigational Site, Duluth, Georgia

Pfizer Investigational Site, Lake Spivey, Georgia

Pfizer Investigational Site, Lawrenceville, Georgia

Pfizer Investigational Site, Macon, Georgia

Pfizer Investigational Site, Marietta, Georgia

Pfizer Investigational Site, Snellville, Georgia

Pfizer Investigational Site, Coeur d' Alene, Idaho

Pfizer Investigational Site, Arlington Heights, Illinois

Pfizer Investigational Site, Aurora, Illinois

Pfizer Investigational Site, Chicago, Illinois

Pfizer Investigational Site, Elk Grove Village, Illinois

Pfizer Investigational Site, Galesburg, Illinois

Pfizer Investigational Site, Winfield, Illinois

Pfizer Investigational Site, Yorkville, Illinois

Pfizer Investigational Site, Avon, Indiana

Pfizer Investigational Site, Beech Grove, Indiana

Pfizer Investigational Site, Hobart, Indiana

Pfizer Investigational Site, Indianapolis, Indiana

Pfizer Investigational Site, Mooresville, Indiana

Pfizer Investigational Site, Munster, Indiana

Pfizer Investigational Site, Cedar Rapids, Iowa

Pfizer Investigational Site, Kansas City, Kansas

Pfizer Investigational Site, Overland Park, Kansas

Pfizer Investigational Site, Shawnee Mission, Kansas

Pfizer Investigational Site, Louisville, Kentucky

Pfizer Investigational Site, Baltimore, Maryland

Pfizer Investigational Site, Lawrence, Massachusetts

Pfizer Investigational Site, Quincy, Massachusetts

Pfizer Investigational Site, Stoneham, Massachusetts

Pfizer Investigational Site, Weymouth, Massachusetts

Pfizer Investigational Site, Worcester, Massachusetts

Pfizer Investigational Site, Detroit, Michigan

Pfizer Investigational Site, Farmington Hills, Michigan

Pfizer Investigational Site, St. Joseph, Michigan

Pfizer Investigational Site, St. Louis Park, Minnesota

Pfizer Investigational Site, Columbus, Mississippi

Pfizer Investigational Site, Corinth, Mississippi

Pfizer Investigational Site, Oxford, Mississippi

Pfizer Investigational Site, Southaven, Mississippi

Pfizer Investigational Site, Tupelo, Mississippi

Pfizer Investigational Site, Kansas City, Missouri

Pfizer Investigational Site, Lee's Summit, Missouri

Pfizer Investigational Site, Lincoln, Nebraska

Pfizer Investigational Site, Las Vegas, Nevada

Pfizer Investigational Site, Lebanon, New Hampshire

Pfizer Investigational Site, Manchester, New Hampshire

Pfizer Investigational Site, Lake Success, New York

Pfizer Investigational Site, Manhasset, New York

Pfizer Investigational Site, New Hyde Park, New York

Pfizer Investigational Site, Oneida, New York

Pfizer Investigational Site, Oswego, New York

Pfizer Investigational Site, Syracuse, New York

Pfizer Investigational Site, Burlington, North Carolina

Pfizer Investigational Site, Canton, Ohio

Pfizer Investigational Site, Cleveland, Ohio

Pfizer Investigational Site, Dover, Ohio

Pfizer Investigational Site, Tulsa, Oklahoma

Pfizer Investigational Site, Clairton, Pennsylvania

Pfizer Investigational Site, Greensburg, Pennsylvania

Pfizer Investigational Site, Johnstown, Pennsylvania

Pfizer Investigational Site, McKeesport, Pennsylvania

Pfizer Investigational Site, Philadelphia, Pennsylvania

Pfizer Investigational Site, Pittsburgh, Pennsylvania

Pfizer Investigational Site, Radnor, Pennsylvania

Pfizer Investigational Site, Sayre, Pennsylvania

Pfizer Investigational Site, Wexford, Pennsylvania

Pfizer Investigational Site, Columbia, South Carolina

Pfizer Investigational Site, Sumter, South Carolina

Pfizer Investigational Site, Bartlett, Tennessee

Pfizer Investigational Site, Knoxville, Tennessee

Pfizer Investigational Site, Maryville, Tennessee

Pfizer Investigational Site, Memphis, Tennessee

Pfizer Investigational Site, Austin, Texas

Pfizer Investigational Site, Dallas, Texas

Pfizer Investigational Site, Fort Sam Houston, Texas

Pfizer Investigational Site, Fort Worth, Texas

Pfizer Investigational Site, Grapevine, Texas

Pfizer Investigational Site, Houston, Texas

Pfizer Investigational Site, Irving, Texas

Pfizer Investigational Site, Longview, Texas

Pfizer Investigational Site, Plano, Texas

Pfizer Investigational Site, Round Rock, Texas

Pfizer Investigational Site, San Antonio, Texas

Pfizer Investigational Site, San Marcos, Texas

Pfizer Investigational Site, Tyler, Texas

Pfizer Investigational Site, Bountiful, Utah

Pfizer Investigational Site, Layton, Utah

Pfizer Investigational Site, Murray, Utah

Pfizer Investigational Site, Provo, Utah

Pfizer Investigational Site, Salt Lake City, Utah

Pfizer Investigational Site, West Valley City, Utah

Pfizer Investigational Site, Arlington, Virginia

Pfizer Investigational Site, Christiansburg, Virginia

Pfizer Investigational Site, Fairfax, Virginia

Pfizer Investigational Site, Gainesville, Virginia

Pfizer Investigational Site, Leesburg, Virginia

Pfizer Investigational Site, Roanoke, Virginia

Pfizer Investigational Site, Salem, Virginia

Pfizer Investigational Site, Winchester, Virginia

Pfizer Investigational Site, Woodbridge, Virginia

Pfizer Investigational Site, Wytheville, Virginia

Pfizer Investigational Site, Seattle, Washington

Pfizer Investigational Site, Spokane Valley, Washington

Pfizer Investigational Site, Spokane, Washington

Pfizer Investigational Site, Albury, New South Wales

Pfizer Investigational Site, Port Macquarie, New South Wales

Pfizer Investigational Site, Geelong, Victoria

Pfizer Investigational Site, Wodonga, Victoria

Pfizer Investigational Site, Linz, Not set

Pfizer Investigational Site, Wien, Not set

Pfizer Investigational Site, Rio de Janeiro, RJ

Pfizer Investigational Site, Higienopolis, Sao Paulo/ Brazil

Pfizer Investigational Site, Sao Paulo, SP

Pfizer Investigational Site, Sofia, Not set

Pfizer Investigational Site, Varna, Not set

Pfizer Investigational Site, Edmonton, Alberta

Pfizer Investigational Site, Levis, Quebec

Pfizer Investigational Site, Nova Ves pod Plesi, Not set

Pfizer Investigational Site, Praha 8, Not set

Pfizer Investigational Site, Pribram I, Not set

Pfizer Investigational Site, Pribram V, Not set

Pfizer Investigational Site, Helsinki, Not set

Pfizer Investigational Site, Pori, Not set

Pfizer Investigational Site, Caen Cedex 05, Not set

Pfizer Investigational Site, Caen Cedex, Not set

Pfizer Investigational Site, Clermond-Ferrand Cedex 01, Not set

Pfizer Investigational Site, Dijon, Not set

Pfizer Investigational Site, Lyon Cedex 04, Not set

Pfizer Investigational Site, Nantes Cedex 2, Not set

Pfizer Investigational Site, Rennes Cedex 9, Not set

Pfizer Investigational Site, Saint Herblain Cedex, Not set

Pfizer Investigational Site, Saint Pierre la Réunion Cedex, Not set

Pfizer Investigational Site, Grosshansdorf, Not set

Pfizer Investigational Site, Karlsruhe, Not set

Pfizer Investigational Site, Leipzig, Not set

Pfizer Investigational Site, Mainz, Not set

Pfizer Investigational Site, Oldenburg, Not set

Pfizer Investigational Site, Thessaloniki, Pylaia

Pfizer Investigational Site, Athens, Not set

Pfizer Investigational Site, Thessaloniki, Not set

Pfizer Investigational Site, Kowloon, Not set

Pfizer Investigational Site, Shatin, New Territories, Not set

Pfizer Investigational Site, Tuen Mun, Not set

Pfizer Investigational Site, Budapest, Not set

Pfizer Investigational Site, Deszk, Not set

Pfizer Investigational Site, Szekesfehervar, Not set

Pfizer Investigational Site, Szombathely, Not set

Pfizer Investigational Site, Torokbalint, Not set

Pfizer Investigational Site, Navrangpura / Ahmedabad, Gujarat

Pfizer Investigational Site, Bangalore, Karnataka

Pfizer Investigational Site, Mumbai, Maharashtra

Pfizer Investigational Site, Nagpur, Maharashtra

Pfizer Investigational Site, New Delhi, Not set

Pfizer Investigational Site, Genova, Not set

Pfizer Investigational Site, Orbassano (TO), Not set

Pfizer Investigational Site, Padova, Not set

Pfizer Investigational Site, Roma, Not set

Pfizer Investigational Site, Kashiwa, Chiba

Pfizer Investigational Site, Matsuyama-shi, Ehime

Pfizer Investigational Site, Gifu-shi, Gifu

Pfizer Investigational Site, Sapporo-shi, Hokkaido

Pfizer Investigational Site, Akashi, Hyogo

Pfizer Investigational Site, Yokohama-city, Kanagawa

Pfizer Investigational Site, Sakai-shi, Osaka-fu

Pfizer Investigational Site, Osaka-city, Osaka

Pfizer Investigational Site, Osakasayama-shi, Osaka

Pfizer Investigational Site, Chuo-Ku, Tokyo

Pfizer Investigational Site, Tokyo, Not set

Pfizer Investigational Site, Gyeonggi-do, Not set

Pfizer Investigational Site, Seoul, Not set

Pfizer Investigational Site, Gdansk, Not set

Pfizer Investigational Site, Krakow, Not set

Pfizer Investigational Site, Siedlce, Not set

Pfizer Investigational Site, Warszawa, Not set

Pfizer Investigational Site, Wroclaw, Not set

Pfizer Investigational Site, Ponce, Not set

Pfizer Investigational Site, Moscow, Not set

Pfizer Investigational Site, Saint-Petersburg, Not set

Pfizer Investigational Site, Samara, Not set

Pfizer Investigational Site, Sochi, Not set

Pfizer Investigational Site, St-Petersburg, Not set

Pfizer Investigational Site, St. Petersburg, Not set

Pfizer Investigational Site, Nitra-Zobor, Not set

Pfizer Investigational Site, Nove Zamky, Not set

Pfizer Investigational Site, Poprad, Not set

Pfizer Investigational Site, L'hospitalet de Llobregat, Barcelona

Pfizer Investigational Site, Santander, Cantabria

Pfizer Investigational Site, Pamplona, Navarra

Pfizer Investigational Site, Cordoba, Not set

Pfizer Investigational Site, Madrid, Not set

Pfizer Investigational Site, Valencia, Not set

Pfizer Investigational Site, Fribourg, Not set

Pfizer Investigational Site, Zuerich, Not set

Pfizer Investigational Site, Niao Sung Hsiang, Kaohsiung Hsien

Pfizer Investigational Site, Tainan, Not set

Pfizer Investigational Site, Taipei, Not set

Pfizer Investigational Site, Adana, Not set

Pfizer Investigational Site, Ankara, Not set

Pfizer Investigational Site, Dnipropetrovsk, Not set

Pfizer Investigational Site, Donetsk, Not set

Pfizer Investigational Site, Kyiv, Not set

Pfizer Investigational Site, Lviv, Not set

Pfizer Investigational Site, Sumy, Not set

Conditions: Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung

Learn More ›

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

NCT00003591

Completed

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy plus paclitaxel in treating patients who have nonmetastatic, unresectable pancreatic cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/11/2013

Locations: Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama +233 locations

Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama

University of Alabama Comprehensive Cancer Center, Birmingham, Alabama

Huntsville Hospital System, Huntsville, Alabama

Urology Associates - Mobile AL, Mobile, Alabama

MBCCOP - University of South Alabama, Mobile, Alabama

Alabama Oncology, LLC, Montgomery, Alabama

Radiation Oncology Associates of West Alabama, Tuscallosa, Alabama

Providence Cancer Therapy Center, Anchorage, Alaska

Arizona Cancer Center, Tucson, Arizona

Providence Saint Joseph Medical Center - Burbank, Burbank, California

Mount Diablo Medical Center, Concord, California

Beckman Research Institute, City of Hope, Duarte, California

California Cancer Center, Fresno, California

Saint Agnes Cancer Center, Fresno, California

Glendale Memorial Hospital and Health Center, Glendale, California

Sutter Health Western Division Cancer Research Group, Greenbrae, California

Loma Linda University Medical Center, Loma Linda, California

Veterans Affairs Medical Center - Long Beach, Long Beach, California

Kaiser Permanente Medical Center - Los Angeles, Los Angeles, California

USC/Norris Comprehensive Cancer Center, Los Angeles, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Veterans Affairs Outpatient Clinic - Martinez, Martinez, California

CCOP - Bay Area Tumor Institute, Oakland, California

Cancer Care Center, Pomona, California

Mercy Medical Center - Redding, Redding, California

Radiation Oncology Center - Sacramento, Sacramento, California

UCSF Cancer Center and Cancer Research Institute, San Francisco, California

Santa Cruz Radiation Oncology Medical Group, Inc., Santa Cruz, California

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California

Stanford University, Stanford, California

David Grant Medical Center, Travis Air Force Base, California

Radiation Oncology Center - Walnut Creek, Walnut Creek, California

Memorial Hospital Cancer Center, Colorado Springs, Colorado

University of Colorado Cancer Center, Denver, Colorado

Bridgeport Hospital, Bridgeport, Connecticut

Whittingham Cancer Center, Norwalk, Connecticut

CCOP - Christiana Care Health Services, Wilmington, Delaware

Walter Reed Army Medical Center, Washington, District of Columbia

Lykes Center for Radiation Therapy, Clearwater, Florida

Halifax Medical Center, Daytona Beach, Florida

Radiation Therapy Associates - Fort Myers, Fort Myers, Florida

University of Florida Health Science Center, Gainesville, Florida

Health First Holmes Regional Medical Center, Melbourne, Florida

CCOP - Mount Sinai Medical Center, Miami Beach, Florida

Sylvester Cancer Center, University of Miami, Miami, Florida

Baptist Hospital of Miami, Miami, Florida

Florida Radiation Oncology Group, Orange Park, Florida

MD Anderson Cancer Center Orlando, Orlando, Florida

Gulf Coast Cancer Treatment Center, Panama City, Florida

West Florida Cancer Institute - Pensacola, Pensacola, Florida

Bayfront Medical Center, Saint Petersburg, Florida

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

CCOP - Atlanta Regional, Atlanta, Georgia

InterCommunity Cancer Center at Rome, Rome, Georgia

South Georgia Medical Center, Valdosta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

University of Chicago Cancer Research Center, Chicago, Illinois

Ingalls Memorial Hospital, Harvey, Illinois

Loyola University Medical Center, Maywood, Illinois

Lutheran General Cancer Care Center, Park Ridge, Illinois

Methodist Medical Center of Illinois, Peoria, Illinois

CCOP - Central Illinois, Springfield, Illinois

CCOP - Carle Cancer Center, Urbana, Illinois

St. John's Medical Center, Anderson, Indiana

Clarion Health Partners Inc., Indianapolis, Indiana

Community Hospitals of Indianapolis - Regional Cancer Center, Indianapolis, Indiana

Ball Memorial Hospital, Muncie, Indiana

Memorial Hospital of South Bend, South Bend, Indiana

St. Joseph's Radiation Oncology Center, South Bend, Indiana

Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Medical Center at Bowling Green, Bowling Green, Kentucky

Veterans Affairs Medical Center - Lexington, Lexington, Kentucky

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

James Graham Brown Cancer Center, Louisville, Kentucky

Louisville Radiation Oncology, Louisville, Kentucky

Merle M. Mahr Cancer Center, Madisonville, Kentucky

Western Baptist Hospital, Paducah, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Romagosa Radiation Oncology Center, Lafayette, Louisiana

East Jefferson General Hospital, Metairie, Louisiana

MBCCOP - LSU Medical Center, New Orleans, Louisiana

CCOP - Ochsner, New Orleans, Louisiana

Maine Medical Center, Portland, Maine

Anne Arundel Oncology Center, Annapolis, Maryland

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland

Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland

Harbor Hospital Center, Baltimore, Maryland

Radiation Oncology Affiliates of Maryland, P.A., Baltimore, Maryland

Johns Hopkins Oncology Center, Baltimore, Maryland

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Joint Center for Radiation Therapy, Boston, Massachusetts

Cape Cod Hospital, Hyannis, Massachusetts

Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

Hurley Medical Center, Flint, Michigan

CCOP - Kalamazoo, Kalamazoo, Michigan

Marquette General Hospital, Marquette, Michigan

St. Mary's Medical Center, Saginaw, Michigan

Mayo Clinic Cancer Center, Rochester, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

Ellis Fischel Cancer Center - Columbia, Columbia, Missouri

CCOP - Kansas City, Kansas City, Missouri

Veterans Affairs Medical Center - Saint Louis, Saint Louis, Missouri

St. Louis University Health Sciences Center, Saint Louis, Missouri

Mallinckrodt Institute of Radiology, Saint Louis, Missouri

Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Ozarks Regional, Springfield, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

Methodist Cancer Center - Omaha, Omaha, Nebraska

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Norris Cotton Cancer Center, Lebanon, New Hampshire

Elliot Regional Cancer Center, Manchester, New Hampshire

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

John F. Kennedy Medical Center, Edison, New Jersey

Elizabeth General Medical Center - West, Elizabeth, New Jersey

South Jersey Hospital - Millville, Millville, New Jersey

Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly, New Jersey

Community Medical Center, Toms River, New Jersey

St. Francis Medical Center, Trenton, New Jersey

Saint Joseph Medical Center, Albuquerque, New Mexico

Cancer Center of Albany Medical Center, Albany, New York

Veterans Affairs Medical Center - Albany, Albany, New York

Albert Einstein Comprehensive Cancer Center, Bronx, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

New York Methodist Hospital, Brooklyn, New York

CCOP - North Shore University Hospital, Manhasset, New York

Kaplan Cancer Center, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York

Vassar Brothers Hospital, Poughkeepsie, New York

Genesee Hospital - Rochester, Rochester, New York

University of Rochester Cancer Center, Rochester, New York

New York Medical College, Valhalla, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

East Carolina University School of Medicine, Greenville, North Carolina

CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina

Meritcare Roger Maris Cancer Center, Fargo, North Dakota

UNI-MED Medical Center, Minot, North Dakota

Akron General Medical Center, Akron, Ohio

Akron City Hospital, Akron, Ohio

Christ Hospital, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

CCOP - Columbus, Columbus, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

Veterans Affairs Medical Center - Dayton, Dayton, Ohio

CCOP - Dayton, Kettering, Ohio

CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio

St. John Medical Center, Tulsa, Oklahoma

Samaritan Regional Cancer Center, Corvallis, Oregon

CCOP - Columbia River Program, Portland, Oregon

Penn State Geisinger Medical Center, Danville, Pennsylvania

Mercy Catholic Medical Center, Mercy Fitzgerald Divison, Darby, Pennsylvania

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Penn State Geisinger Cancer Center, Hershey, Pennsylvania

Allegheny University Hospitals- Hahnemann, Philadelphia, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Albert Einstein Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Reading Hospital and Medical Center, Reading, Pennsylvania

Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania

Grand View Hospital, Sellersville, Pennsylvania

Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania

CCOP - MainLine Health, Wynnewood, Pennsylvania

York Hospital, York, Pennsylvania

Lifespan: The Miriam Hospital, Providence, Rhode Island

Roger Williams Medical Center/Brown University, Providence, Rhode Island

Medical University of South Carolina, Charleston, South Carolina

CCOP - Greenville, Greenville, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

Jackson-Madison County General Hospital, Jackson, Tennessee

Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee

CCOP - Baptist Cancer Institute, Memphis, Tennessee

University of Tennessee, Memphis Cancer Center, Memphis, Tennessee

Vanderbilt Cancer Center, Nashville, Tennessee

Julie and Ben Rogers Cancer Institute, Beaumont, Texas

University of Texas Medical Branch, Galveston, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

Wilford Hall - 59th Medical Wing, Lackland Air Force Base, Texas

Bayshore Medical Center, Pasadena, Texas

Dixie Regional Medical Center, Saint George, Utah

LDS Hospital, Salt Lake City, Utah

CCOP - Southwestern Vermont Regional Cancer Center, Bennington, Vermont

Green Mountain Oncology Group, Rutland, Vermont

Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont

Martha Jefferson Hospital, Charlottesville, Virginia

Cancer Center, University of Virginia HSC, Charlottesville, Virginia

Virginia Baptist Hospital, Lynchburg, Virginia

Naval Medical Center, Portsmouth, Portsmouth, Virginia

Massey Cancer Center, Richmond, Virginia

Swedish Hospital Tumor Institute, Seattle, Washington

Virginia Mason Medical Center, Seattle, Washington

Deaconess Medical Center, Spokane, Washington

Yakima Valley Memorial Hospital, Yakima, Washington

Schiffler Oncology Center, Wheeling, West Virginia

St. Vincent Hospital, Green Bay, Wisconsin

Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin

Veterans Affairs Medical Center - Madison, Madison, Wisconsin

Southern Wisconsin Radiotherapy Center, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Marshfield Clinic, Marshfield, Wisconsin

Community Memorial Hospital, Menomonee Falls, Wisconsin

St. Joseph's Hospital, Milwaukee, Wisconsin

Columbia Hospital, Milwaukee, Wisconsin

St. Luke's Medical Center, Milwaukee, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin

Southeastern Wisconsin Regional Cancer Center, Racine, Wisconsin

Tom Baker Cancer Center - Calgary, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia

Doctor Leon Richard Oncology Centre, Moncton, New Brunswick

Saint John Regional Hospital, Saint John, New Brunswick

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Kingston Regional Cancer Centre, Kingston, Ontario

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario

Ottawa Regional Cancer Centre - Civic Campus, Ottawa, Ontario

Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario

Princess Margaret Hospital, Toronto, Ontario

McGill University Department of Oncology, Montreal, Quebec

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Conditions: Pancreatic Cancer

Learn More ›

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

NCT00147537

Completed

Phase 1b Dose Excalation/Expansion: Identify and characterize safety and tolerability of recommended phase 2 dose of CP-751,871 when administered with paclitaxel and carboplatin Phase 1b Erlotinib Extension: To characterize the safety and tolerability of CP751,871 when administered with paclitaxel, carboplatin and erlotinib. Phase 2: To test the efficacy of CP-751,871 combined with paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/01/2013

Locations: Pfizer Investigational Site, Tucson, Arizona +30 locations

Pfizer Investigational Site, Tucson, Arizona

Pfizer Investigational Site, Greenbrae, California

Pfizer Investigational Site, Los Angeles, California

Pfizer Investigational Site, Jacksonville, Florida

Pfizer Investigational Site, Jeffersonville, Indiana

Pfizer Investigational Site, Louisville, Kentucky

Pfizer Investigational Site, Shelbyville, Kentucky

Pfizer Investigational Site, Baltimore, Maryland

Pfizer Investigational Site, Rochester, Minnesota

Pfizer Investigational Site, Corinth, Mississippi

Pfizer Investigational Site, Southaven, Mississippi

Pfizer Investigational Site, Creve Coeur, Missouri

Pfizer Investigational Site, St. Louis, Missouri

Pfizer Investigational Site, St. Peters, Missouri

Pfizer Investigational Site, Bronx, New York

Pfizer Investigational Site, Philadelphia, Pennsylvania

Pfizer Investigational Site, Memphis, Tennessee

Pfizer Investigational Site, Houston, Texas

Pfizer Investigational Site, Montreal, Quebec

Pfizer Investigational Site, Orbassano (TO), Not set

Pfizer Investigational Site, L'hospitalet de Llobregat, Barcelona

Pfizer Investigational Site, Madrid, Not set

Pfizer Investigational Site, Sevilla, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer

NCT00003378

Terminated

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients with previously untreated stage III or stage IV ovarian or primary peritoneal cancer.

Gender:

FEMALE

Ages:

Between 18 years and 80 years

Trial Updated:

07/08/2013

Locations: University of Alabama Comprehensive Cancer Center, Birmingham, Alabama +63 locations

University of Alabama Comprehensive Cancer Center, Birmingham, Alabama

CCOP - Greater Phoenix, Phoenix, Arizona

USC/Norris Comprehensive Cancer Center, Los Angeles, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Women's Cancer Center, Palo Alto, California

University of Colorado Cancer Center, Denver, Colorado

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia

Walter Reed Army Medical Center, Washington, District of Columbia

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

CCOP - Atlanta Regional, Atlanta, Georgia

MBCCOP - Hawaii, Honolulu, Hawaii

Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois

University of Chicago Cancer Research Center, Chicago, Illinois

CCOP - Evanston, Evanston, Illinois

CCOP - Central Illinois, Springfield, Illinois

Indiana University Cancer Center, Indianapolis, Indiana

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

Johns Hopkins Oncology Center, Baltimore, Maryland

Medicine Branch, Bethesda, Maryland

Radiation Oncology Branch, Bethesda, Maryland

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

University of Mississippi Medical Center, Jackson, Mississippi

Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi

CCOP - Kansas City, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Cooper Hospital/University Medical Center, Camden, New Jersey

Cancer Center of Albany Medical Center, Albany, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

North Shore University Hospital, Manhasset, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

University of Rochester Cancer Center, Rochester, New York

State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

Duke Comprehensive Cancer Center, Durham, North Carolina

Brookview Research, Inc., Winston-Salem, North Carolina

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina

Barrett Cancer Center, The University Hospital, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

Cleveland Clinic Cancer Center, Cleveland, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center, Tulsa, Oklahoma

CCOP - Columbia River Program, Portland, Oregon

Abington Memorial Hospital, Abington, Pennsylvania

Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Pennsylvania Hospital, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

CCOP - Baptist Cancer Institute, Memphis, Tennessee

Simmons Cancer Center - Dallas, Dallas, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

University of Washington Medical Center, Seattle, Washington

Tacoma General Hospital, Tacoma, Washington

NCIC-Clinical Trials Group, Kingston, Ontario

Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer

Learn More ›

Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

NCT00003691

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy consisting of doxorubicin and cisplatin with or without paclitaxel and G-CSF in treating patients who have stage III, stage IV, or recurrent endometrial cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/08/2013

Locations: University of Alabama Comprehensive Cancer Center, Birmingham, Alabama +72 locations

University of Alabama Comprehensive Cancer Center, Birmingham, Alabama

CCOP - Greater Phoenix, Phoenix, Arizona

USC/Norris Comprehensive Cancer Center, Los Angeles, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

Chao Family Comprehensive Cancer Center, Orange, California

Women's Cancer Center, Palo Alto, California

University of Colorado Cancer Center, Denver, Colorado

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia

Walter Reed Army Medical Center, Washington, District of Columbia

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

MBCCOP - Hawaii, Honolulu, Hawaii

MBCCOP - University of Illinois at Chicago, Chicago, Illinois

Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois

University of Chicago Cancer Research Center, Chicago, Illinois

CCOP - Central Illinois, Decatur, Illinois

CCOP - Evanston, Evanston, Illinois

Indiana University Cancer Center, Indianapolis, Indiana

CCOP - Iowa Oncology Research Association, Des Moines, Iowa

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

Johns Hopkins Oncology Center, Baltimore, Maryland

Medicine Branch, Bethesda, Maryland

Radiation Oncology Branch, Bethesda, Maryland

Tufts University School of Medicine, Boston, Massachusetts

Memorial Hospital, Worcester, Massachusetts

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

University of Minnesota Cancer Center, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi

CCOP - Kansas City, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Cooper Hospital/University Medical Center, Camden, New Jersey

Cancer Center of Albany Medical Center, Albany, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

North Shore University Hospital, Manhasset, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

University of Rochester Cancer Center, Rochester, New York

State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

Duke Comprehensive Cancer Center, Durham, North Carolina

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina

Barrett Cancer Center, The University Hospital, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

Cleveland Clinic Cancer Center, Cleveland, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

CCOP - Sooner State, Tulsa, Oklahoma

CCOP - Columbia River Program, Portland, Oregon

Abington Memorial Hospital, Abington, Pennsylvania

Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Pennsylvania Hospital, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

CCOP - MainLine Health, Wynnewood, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

CCOP - Greenville, Greenville, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

CCOP - Baptist Cancer Institute, Memphis, Tennessee

Brookview Research, Inc., Nashville, Tennessee

Simmons Cancer Center - Dallas, Dallas, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

CCOP - Scott and White Hospital, Temple, Texas

Cancer Center, University of Virginia HSC, Charlottesville, Virginia

University of Washington Medical Center, Seattle, Washington

Tacoma General Hospital, Tacoma, Washington

NCIC-Clinical Trials Group, Kingston, Ontario

Conditions: Endometrial Cancer

Learn More ›